Presspart to Exhibit at Nasal Drug Delivery Annual International Conference 2015

Share Article

Pharmaceutical medical device component manufacturers Presspart will be exhibiting at the Nasal Drug Delivery Annual International Conference in London on the 16th and 17th April 2015.

Presspart logo
This conference is an excellent opportunity for us to connect with recognised experts in the area of nasal drug delivery.

Presspart Manufacturing, a world leader in the production of dispensing actuators and other pharmaceutical medical device components, will be exhibiting at the Nasal Drug Delivery Annual International Conference at the Rembrandt Hotel in London on the 16th and 17th of April. The conference brings together an international panel of experts as well as industry leaders to discuss advances in drug therapies, systemic delivery and device technologies, and includes an onsite exhibition where companies who manufacture nasal drug delivery technology, such as Presspart, can showcase and market their product developments.

Whilst better known as suppliers of respiratory drug delivery devices, Presspart also manufacture a range of high quality healthcare dispensing actuators, which they will be showcasing at the conference. Alongside nasal dispensing actuators, this range includes dispensers for oral, ear and topical applications. Manufactured in ISO 7 and ISO 8 standard clean rooms in their facility in Tarragona, Spain, Presspart’s nasal dispensing actuators meet global regulatory standards for the medical and pharmaceutical device market. Their standard designs fit all the main industry valves and pumps, and they are also able to develop new actuators in-house to meet specific needs, taking the product from concept to full industrialisation.

A spokesperson for Presspart said; “This conference is an excellent opportunity for us to connect with recognised experts in the area of nasal drug delivery. As we develop new products it is naturally important for us to keep up to date on the latest developments and research in this area, and as we are currently working on development of a new nasal actuator we are looking forward to some valuable insights from the speakers present.”

Presspart is the market leader in bespoke deep-drawn and injection-moulded components for the pharmaceutical and other specialist industrial markets. They have decades of experience in precision manufacturing, partnering with the world’s leading pharmaceutical companies to assist with the product and device development process as new drugs come on to the market. With a specialist emphasis on metered-dose inhalers and actuators, they understand that there is nothing more important than enhancing the quality of life – from the broadest concept to the smallest detail.

For more information about Presspart or to learn more about their dispensing actuators and other products, please visit http://www.presspart.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chad Mayoh
Presspart
+44 1254 586278
Email >
Visit website